FDA Device Center Analyzes Why It Missed PMA Review Goals
FDA pre-market approval reviews tend to take longer when the medical officer leaves the review team, when clinical trial data issues arise and when companies engage in "excessive" back and forth with FDA during the review process, according to a recent FDA analysis.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
